Early-access Use of Radioligand Therapy in Prostate Cancer. // European Urology Focus. – URL: https://www.sciencedirect.com/science/article/pii/S2405456926000787?dgcid=rss_sd_all
Early-access Use of Radioligand Therapy in Prostate Cancer. European Urology Focus. https://www.sciencedirect.com/science/article/pii/S2405456926000787?dgcid=rss_sd_all
“Early-access Use of Radioligand Therapy in Prostate Cancer.” European Urology Focus.
@article{article45729,
title = {Early-access Use of Radioligand Therapy in Prostate Cancer},
journal = {European Urology Focus},
url = {https://www.sciencedirect.com/science/article/pii/S2405456926000787?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...